Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with an incidence of 0.5-1%
in the general population, and the prevalence increases with age (1) . AF is associated with increased morbidity and mortality (1) . There are several treatments for AF but the Cox-maze III cut and sew surgical procedure is the one with the best results in terms of restored sinus rhythm at long-term follow-up (2, 3) . This procedure is still the reference standard for surgical treatment of AF but it is mostly used in stand-alone surgery for AF due to its technical complexity (4) . Ablative lesions created with different energy sources (Cox-maze IV) have mainly replaced the cut and sew lines in AF treatment concomitant to other cardiac surgery (5, 6).
The 2012 Heart Rhythm Society/European Heart Rhythm Society/European Cardiac Arrhythmia Society guidelines recommend AF intervention as an acceptable treatment in symptomatic patients, concomitant to other cardiac surgery (7) . Theories and studies that suggest a decreased risk for stroke, an improved quality of life, a decreased risk for heart failure, and an improved survival with achievement of sinus rhythm after cardiac surgery have led to a more liberal implementation of concomitant AF procedure, particularly in mitral valve surgery (MVS) (7, 8) .
AF treatment added to other cardiac surgery does not seem to increase short-term mortality, reoperation for bleeding, stroke, low cardiac output syndrome, deep sternal wound infection, prolonged ventilation, or renal failure (8) (9) (10) . However, it increases the cross-clamp time (CCT) and the intensive care unit stay, and it may increase the need for a permanent pacemaker postoperatively (8, (11) (12) (13) .
Postoperative heart failure (PHF) is one of the major determinants for adverse outcome in cardiac surgery (14) (15) (16) . Most of the in-hospital mortality after coronary bypass surgery is Boano et al. 4 related to PHF, and patients with PHF after surgery for aortic stenosis have a 42% mortality rate at five-year follow-up (16) . Our hypothesis was that the Cox-maze IV cryoablation procedure added to MVS is associated with PHF and other adverse short-term outcomes.
Material and methods
Consecutive patients with preoperative nonparoxysmal AF undergoing MVS between Nov 2009 and June 2013 were identified in our institutional database. Sixty-six patients had no concomitant ablation procedure (No-maze group) and 50 patients had concomitant Cox-maze IV biatrial cryoablation (Maze group), using the argon powered Cardioblate® CryoFlex™ Surgical Ablation Probe (Medtronic Inc., Minneapolis, MN, USA). The decision to add the Cox-maze IV procedure to MVS was made by the surgeon. The cryoablation probe was applied for 120 seconds at full power and usually it reached -150°C but always at least -130°C. The removal of the probe was aided by irrigation with warm saline. The left atrial lesion set consisted of a circular line isolating the four pulmonary vein orifices, a coronary sinus lesion from the atrial incision through the mitral annulus, and a left atrial appendage line connected to the circular pulmonary vein lesion. The right atrial lesions included an intercaval line between the superior and the inferior vena cava crossing the right atrial incision, a "T" lesion from the right atrial incision to the posterior portion of the tricuspid annulus, and a lesion from the right atrial appendage to the anterior portion of the tricuspid annulus (17) . 
Clinical management
Standard monitoring was used consisting of a five-lead electrocardiogram, pulse oximetry, continuous arterial blood pressure monitoring, central venous pressure, and transoesophageal echocardiography. A median sternotomy was performed and combined anterograde and retrograde blood cardioplegia was employed in all patients. A surgical pulmonary artery catheter was introduced in all patients before weaning from extracorporeal circulation (18) .
Echocardiography
Images were recorded from standard views, according to the recommendations of the American Society of Echocardiography for transthoracic studies (19) . The long-axis parasternal view was used to derive the M-mode measurement of the left ventricular diameter.
The right ventricular inflow diameter and the left and right atrial areas were calculated from the four chamber view. Tricuspid annular plane systolic excursion was recorded at the right ventricular free wall using the cross sectional guided M-mode. The systolic pulmonary arterial pressure was calculated using the tricuspid regurgitation velocity to obtain a systolic transvalvular pressure gradient. Estimated right atrial pressure based on vena cava size and collapse was then added to the obtained gradient. The systolic left ventricular function was assessed using eyeballing combining the regional ventricular function abnormalities and the haemodynamic adaptation to eventual volume overload. The result was graded in normal, mild, moderate or severe left ventricular dysfunction.
Statistical analysis
Categorical variables are presented as numbers (percent) and continuous variables as medians 
Results
The surgical procedures are listed in Table 1 . Fewer coronary artery bypass procedures were performed in the Maze group compared to the No-maze group, five(10%) v 21(32%), p=0.006.
Preoperative and intraoperative data
The baseline characteristics for both groups are given in Table 2 . The patients in the Maze group were younger, less frequently had a history of angina pectoris, were in lower NYHA classes, had higher blood haemoglobin, and they also had higher creatinine clearance. 
Postoperative outcomes
Markers for myocardial injury were significantly higher in the Maze group on the first postoperative day. Postoperative in-hospital results are shown in Table 3 . At discharge from our hospital, 32(64%) of the patients in the Maze group were free from AF and at the oneyear follow-up, 40(83%) had no evidence of AF. The need for permanent pacemaker Boano et al. 
Variables associated with PHF
Univariate associations between PHF and variables of interest are given in 
Discussion
Surgeons' concern about increased morbidity associated with the Cox-maze IV procedure may partly explain why most of the cardiac surgery patients with AF are left untreated in spite of the present recommendations (8, 20, 21) . The selection of patients for concomitant surgical AF treatment is based on symptoms but is also influenced by expected success contra complication rates. In the case of structural cardiac pathology, arrhythmia-related symptoms such as fatigue and effort intolerance are often difficult to distinguish from symptoms related to valve dysfunction. As seen in our study, MVS in patients with AF includes, to a large extent, patients in need of other cardiac surgery procedures, which increases the surgical complexity and suggests a higher risk of adverse outcomes. Better definition of parameters correlated to adverse outcome would enhance patient selection.
The connection we found between PHF and early postoperative morbidity is in accordance with previous studies on other patient categories (14, 16, 22) . The incidence of PHF was 41% in patients with AF undergoing MVS in our study, which is higher than the reported 5-15% of PHF for other cardiac surgery patient groups (23) (24) (25) (26) . In this study, PHF presented at weaning from extracorporeal circulation and was associated with prolonged respiratory treatment and increased renal impairment. The 2.0% one-year mortality in patients with PHF was lower than the predicted early postoperative mortality indicated by EuroSCORE II (5.8%) and it was considerably lower than in patients with PHF after coronary surgery (25.5%) (16) . In patients with PHF after surgery for aortic stenosis, an 8.9% one-year mortality was reported but the mortality rose to 42.2% at the five-year follow-up (16) . Obviously the impact of PHF on postoperative mortality is different for different patient groups. Whether PHF has a larger impact on the long-term mortality than it has on the one-year mortality in patients with AF undergoing MVS remains to be shown.
Patients in the Maze group were younger, had a lower rate of coronary artery disease, were in lower NYHA classes, had a higher blood haemoglobin level, higher creatinine clearance, better longitudinal right ventricle function, and lower pulmonary artery pressure. However, we found no significant differences in postoperative outcome with regard to mortality, stroke, reoperation for bleeding, postoperative renal failure or length of intensive care unit stay between the two groups.
In spite of the more favourable preoperative state of the Maze group, the incidence of PHF was close to significantly higher compared with the No-maze group (50% v 33%, p=0.09).
The strong association of CCT and congestive heart failure with PHF was, however, not confounded by the Cox-maze IV procedure. We cannot preclude that the Cryo-maze procedure increases the risk of PHF in patients with congestive heart failure undergoing complex cardiac surgery, not least by adding approximately 30 minutes to the CCT.
Preoperative left ventricular dysfunction seems to play a less important role for PHF after MVS in patients with AF than in patients operated upon for aortic stenosis (22) . Perioperative myocardial infarction is related to PHF after both coronary and aortic stenosis surgery (22, 23) . The cryoablation procedure itself results in elevation of markers for myocardial injury by atrial myocyte destruction (27) . This prevents evaluation of the perioperative ventricular injury and thereby the diagnosis of perioperative myocardial infarction.
The Cox-maze IV cryoablation procedure seems not to affect the need for a permanent pacemaker when conducted concomitant to MVS in spite of the 83% freedom from AF in the Maze group at the one-year follow-up. The reported freedom of AF one year after MVS without concomitant AF procedure is varying from approximately 30-43% (12, 28) .
This study has certain limitations that should be acknowledged. It was not prospective and the patient selection for concomitant maze surgery was based on the surgeon's decision which means the groups were not fully comparable. Conclusions on outcome comparisons between the groups must be made with caution. The limited size of the groups and the low incidence of early postoperative mortality impede an analysis of factors related to one-year mortality.
There is no generally accepted criterion for PHF and our definition is dependent on the individual judgement of various surgeons and anaesthesiologists which may partly explain the high incidence of PHF in our patients with AF undergoing MVS. However, this definition of PHF applied on aortic valve surgery and coronary artery surgery resulted in 11% and 12% of PHF, respectively, which is comparable whith the 5-15% of PHF in other studies on aortic valve and coronary artery surgery (23) . At our institution a reliance on mixed venous oxygen saturation and echocardiographic appearance rather than fixed haemodynamic criteria are used to diagnose PHF (22, 23) .
Summary
We cannot exclude that the addition of the Cox-maze IV cryoablation procedure to MVS increases the risk for postoperative heart failure. It can, however, be conducted with a low one-year mortality at least in a selected group of younger patients in a lower New York Heart
Association class, and with a better renal function. A concomitant cryo-maze procedure should be applied with caution in patients needing complex surgical procedures with long expected CCT. PHF after MVS in patients with preoperative AF is frequent and results in prolonged ventilator treatment and increased time in the intensive care unit. Tables   Table 1. The different Table 2 . Results are given as n (%) or as median (1st -3rd quartile). BSA = body surface area; LA = left atrium; LV = left ventricle; RA= right atrium; RV = right ventricle. 
